Nisa Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,391
Closed -$1.08M 2795
2022
Q3
$1.08M Buy
4,391
+268
+7% +$72.4K 0.01% 786
2022
Q2
$1.02M Sell
4,123
-2,554
-38% -$689K 0.01% 822
2022
Q1
$2.21M Buy
+6,677
New +$2.06M 0.02% 643
2021
Q4
Sell
-17,632
Closed -$5.74K 2354
2021
Q3
$5.74K Sell
17,632
-3,951
-18% -$1.34M 0.03% 408
2021
Q2
$6.74K Buy
21,583
+11,599
+116% +$3.56M 0.04% 358
2021
Q1
$3.18K Sell
9,984
-8,128
-45% -$2.6M 0.02% 587
2020
Q4
$5.87M Sell
18,112
-20,817
-53% -$5.76M 0.04% 399
2020
Q3
$10.8M Buy
38,929
+30,059
+339% +$8.66M 0.09% 226
2020
Q2
$2.14M Buy
8,870
+1,920
+28% +$386K 0.02% 571
2020
Q1
$1.01M Buy
6,950
+6,010
+639% +$998K 0.01% 698
2019
Q4
$160K Buy
940
+230
+32% +$42.6K ﹤0.01% 1361
2019
Q3
$126K Sell
710
-808
-53% -$175K ﹤0.01% 1418
2019
Q2
$395K Sell
1,518
-10,845
-88% -$2.88M ﹤0.01% 1149
2019
Q1
$3.53M Sell
12,363
-2,234
-15% -$742K 0.03% 453
2018
Q4
$4.75M Sell
14,597
-48,254
-77% -$16.8M 0.05% 338
2018
Q3
$24.6M Buy
62,851
+7,460
+13% +$2.94M 0.22% 104
2018
Q2
$21.2M Buy
+55,391
New +$20.1M 0.22% 103
2016
Q2
Sell
-500
Closed -$47K 1887
2016
Q1
$47K Buy
+500
New +$42.2K ﹤0.01% 1403

Other funds holding ABMD

Nisa Investment Advisors's ABMD Position: Q4 2022 in Review

Nisa Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,391 shares — an estimated $1.08M sold.

Nisa Investment Advisors first reported a position in ABMD in Q1 2016 and held it in 18 quarters. The position peaked at $24.6M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Nisa Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Nisa Investment Advisors sold 4,391 Abiomed Inc shares in Q4 2022, an estimated $1.08M.
  • Nisa Investment Advisors first reported a position in Abiomed Inc in Q1 2016 and held it in 18 quarters.
  • Nisa Investment Advisors's Abiomed Inc position peaked at $24.6M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Nisa Investment Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.